<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"></head><body style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;" class=""><div class=""><br class=""></div>Anne,<div class=""><br class=""></div><div class="">The exact quote from Karen's report is as this:</div><div class=""><br class=""></div><div class="">"Given these findings, the recommendation is
that Studies 2 and 3 should not be performed as currently designed. Regarding
Study 2, analyzing datasets is unlikely to identify significant root causes for
name collisions that have not already been identified. New causes for name
collisions are far more likely to be found by investigating TLD candidates for
potential delegation on a case by case basis. Regarding Study 3, the review of
prior work has not identified any new mitigation strategies for name collisions
to be tested. Also, controlled interruption has already proven an effective
mitigation strategy. Without a compelling new mitigation strategy to consider, Study
3 does not seem to be needed at this time.<p class="MsoNormal"><span lang="EN-US" class="">All of that being said, this does not mean
further study should not be conducted into name collision risks and the
feasibility of potentially delegating additional domains that are likely to
cause name collisions. However, the proposals for Studies 2 and 3 do not seem
to still be effective ways of achieving those goals."</span></p><div class=""><br class=""></div><div class="">I think her words are self-explanatory of her views, which have already been endorsed in the NCAP mailing list by Jeff Schimdt. </div><div class=""><br class=""></div><div class=""><br class=""></div><div class=""><br class=""></div><div class=""><br class=""></div><div class="">Rubens</div><div class=""><br class=""></div><div class=""><br class=""></div><div><blockquote type="cite" class=""><div class="">On 28 Apr 2020, at 19:14, Aikman-Scalese, Anne <<a href="mailto:AAikman@lrrc.com" class="">AAikman@lrrc.com</a>> wrote:</div><br class="Apple-interchange-newline"><div class=""><div class="WordSection1" style="page: WordSection1; caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none;"><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><span style="color: rgb(31, 73, 125);" class="">HI Jeff,<o:p class=""></o:p></span></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><span style="color: rgb(31, 73, 125);" class="">I listened to last night’s Sub Pro call (which I was unable to attend). In that call, you advised the Sub Pro Working Group verbally that the independent contractor for NCAP Study 1, Karen Scarfone, had made a Study 1 recommendation against proceeding to Study 2 and 3. You also stated that “not everyone” in the NCAP Discussion Group agrees with Karen’s recommendation that Study 2 and 3 should not proceed.<o:p class=""></o:p></span></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><span style="color: rgb(31, 73, 125);" class=""><o:p class=""> </o:p></span></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><span style="color: rgb(31, 73, 125);" class="">I can’t quite figure out why you believe that Karen made such a recommendation. It would be good if you could clarify this before the April 30 call on Name Collisions. Please reply to all.<o:p class=""></o:p></span></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><span style="color: rgb(31, 73, 125);" class=""><o:p class=""> </o:p></span></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><span style="color: rgb(31, 73, 125);" class="">Thank you,<o:p class=""></o:p></span></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><span style="color: rgb(31, 73, 125);" class="">Anne<o:p class=""></o:p></span></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><span style="color: rgb(31, 73, 125);" class=""><o:p class=""> </o:p></span></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><span style="color: rgb(31, 73, 125);" class=""><o:p class=""> </o:p></span></div><div class=""><div style="border-style: solid none none; border-top-width: 1pt; border-top-color: rgb(225, 225, 225); padding: 3pt 0in 0in;" class=""><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><b class="">From:</b><span class="Apple-converted-space"> </span>NCAP-Discuss <<a href="mailto:ncap-discuss-bounces@icann.org" style="color: purple; text-decoration: underline;" class="">ncap-discuss-bounces@icann.org</a>><span class="Apple-converted-space"> </span><b class="">On Behalf Of<span class="Apple-converted-space"> </span></b>Jeff Neuman<br class=""><b class="">Sent:</b><span class="Apple-converted-space"> </span>Monday, April 27, 2020 8:59 AM<br class=""><b class="">To:</b><span class="Apple-converted-space"> </span>Matt Larson <<a href="mailto:matt.larson@icann.org" style="color: purple; text-decoration: underline;" class="">matt.larson@icann.org</a>><br class=""><b class="">Cc:</b><span class="Apple-converted-space"> </span><a href="mailto:ncap-discuss@icann.org" style="color: purple; text-decoration: underline;" class="">ncap-discuss@icann.org</a><br class=""><b class="">Subject:</b><span class="Apple-converted-space"> </span>Re: [NCAP-Discuss] [Ext] Re: Draft final Study 1 report<o:p class=""></o:p></div></div></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><o:p class=""> </o:p></div><div class=""><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><strong class=""><span style="font-size: 9pt; font-family: Helvetica, sans-serif;" class="">[EXTERNAL]</span></strong><span style="font-size: 9pt; font-family: Helvetica, sans-serif;" class=""><o:p class=""></o:p></span></div><div class="MsoNormal" align="center" style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif; text-align: center;"><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><hr size="2" width="100%" align="center" class=""></span></div></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class="">Thanks Matt. I forwarded to the SubPro Group your original e-mail which contained the study and your cover note.<o:p class=""></o:p></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><o:p class=""> </o:p></div><div class=""><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><b class=""><span lang="EN-GB" style="font-size: 9pt; font-family: Arial, sans-serif;" class="">Jeff Neuman</span></b><span lang="EN-GB" style="font-size: 9pt; font-family: Arial, sans-serif;" class=""><o:p class=""></o:p></span></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><span lang="EN-GB" style="font-size: 9pt; font-family: Arial, sans-serif;" class="">Senior Vice President <o:p class=""></o:p></span></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><b class=""><span lang="EN-GB" style="font-size: 9pt; font-family: Arial, sans-serif;" class="">Com Laude | Valideus</span></b><span lang="EN-GB" style="font-size: 9pt; font-family: Arial, sans-serif;" class=""><o:p class=""></o:p></span></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><span lang="EN-GB" style="font-size: 9pt; font-family: Arial, sans-serif;" class="">D: +1.703.635.7514<o:p class=""></o:p></span></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><span lang="EN-GB" style="font-size: 9pt; font-family: Arial, sans-serif;" class="">E:<span class="Apple-converted-space"> </span></span><u class=""><span lang="EN-GB" style="font-size: 9pt; font-family: Arial, sans-serif; color: rgb(5, 99, 193);" class=""><a href="mailto:jeff.neuman@comlaude.com" style="color: purple; text-decoration: underline;" class="">jeff.neuman@comlaude.com</a><o:p class=""></o:p></span></u></div></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><o:p class=""> </o:p></div><div class=""><div style="border-style: solid none none; border-top-width: 1pt; border-top-color: rgb(225, 225, 225); padding: 3pt 0in 0in;" class=""><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><b class="">From:</b><span class="Apple-converted-space"> </span>Matt Larson <<a href="mailto:matt.larson@icann.org" style="color: purple; text-decoration: underline;" class="">matt.larson@icann.org</a>><span class="Apple-converted-space"> </span><br class=""><b class="">Sent:</b><span class="Apple-converted-space"> </span>Monday, April 27, 2020 11:29 AM<br class=""><b class="">To:</b><span class="Apple-converted-space"> </span>Jeff Neuman <<a href="mailto:jeff.neuman@comlaude.com" style="color: purple; text-decoration: underline;" class="">jeff.neuman@comlaude.com</a>><br class=""><b class="">Cc:</b><span class="Apple-converted-space"> </span><a href="mailto:ncap-discuss@icann.org" style="color: purple; text-decoration: underline;" class="">ncap-discuss@icann.org</a><br class=""><b class="">Subject:</b><span class="Apple-converted-space"> </span>Re: [NCAP-Discuss] [Ext] Re: Draft final Study 1 report<o:p class=""></o:p></div></div></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><o:p class=""> </o:p></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class="">Hi, Jeff, everyone.<o:p class=""></o:p></div><div class=""><p class="MsoNormal" style="margin: 0in 0in 12pt; font-size: 11pt; font-family: Calibri, sans-serif;"><o:p class=""> </o:p></p><blockquote style="margin-top: 5pt; margin-bottom: 5pt;" class=""><div class=""><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class="">On Apr 27, 2020, at 8:01 AM, Jeff Neuman <<a href="mailto:jeff.neuman@comlaude.com" style="color: purple; text-decoration: underline;" class="">jeff.neuman@comlaude.com</a>> wrote:<o:p class=""></o:p></div></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><o:p class=""> </o:p></div><div class=""><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><span style="font-size: 10.5pt; font-family: CourierNewPSMT;" class="">The SubPro Working Group is discussing the issue of Name Collisions on its Thursday call. Is this list public? And if so, can I post the latest document to the SubPro list so that they can see the current state of the studies? I would be happy to post other comments you all have to the report as well that you would want shared.</span><o:p class=""></o:p></div></div></blockquote></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><o:p class=""> </o:p></div><div class=""><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class="">This list has public archives, so anyone can see my message with the current draft attached. If you want to share on the SubPro list, could I please suggest that you point people to my message in the archives rather than send the document itself? That link is<span class="Apple-converted-space"> </span><a href="https://mm.icann.org/pipermail/ncap-discuss/2020-April/000275.html" style="color: purple; text-decoration: underline;" class="">https://mm.icann.org/pipermail/ncap-discuss/2020-April/000275.html</a>. Sharing the document that way will hopefully help keep the context clear, specifically, that this report is not final.<o:p class=""></o:p></div></div><div class=""><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><o:p class=""> </o:p></div></div><div class=""><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class="">Matt<o:p class=""></o:p></div></div><div class=""><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><o:p class=""> </o:p></div></div><div class="MsoNormal" align="center" style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif; text-align: center;"><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><hr size="2" width="100%" align="center" class=""></span></div><div style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">The contents of this email and any attachments are confidential to the intended recipient. They may not be disclosed, used by or copied in any way by anyone other than the intended recipient. If you have received this message in error, please return it to the sender (deleting the body of the email and attachments in your reply) and immediately and permanently delete it. Please note that the Com Laude Group does not accept any responsibility for viruses and it is your responsibility to scan or otherwise check this email and any attachments. The Com Laude Group does not accept liability for statements which are clearly the sender's own and not made on behalf of the group or one of its member entities. The Com Laude Group includes Nom-IQ Limited t/a Com Laude, a company registered in England and Wales with company number 5047655 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Valideus Limited, a company registered in England and Wales with company number 06181291 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Demys Limited, a company registered in Scotland with company number SC197176, having its registered office at 33 Melville Street, Edinburgh, Lothian, EH3 7JF Scotland; Consonum, Inc. dba Com Laude USA and Valideus USA, headquartered at 1751 Pinnacle Drive, Suite 600, McLean, VA 22102, USA; Com Laude (Japan) Corporation, a company registered in Japan having its registered office at Suite 319,1-3-21 Shinkawa, Chuo-ku, Tokyo, 104-0033, Japan. For further information see<span class="Apple-converted-space"> </span><a href="https://comlaude.com/" target="_blank" style="color: purple; text-decoration: underline;" class="">www.comlaude.com</a><o:p class=""></o:p></span></div></div><br style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none;" class=""><hr style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none;" class=""><font face="Arial" color="Gray" size="1" style="font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; text-decoration: none;" class=""><br class="">This message and any attachments are intended only for the use of the individual or entity to which they are addressed. If the reader of this message or an attachment is not the intended recipient or the employee or agent responsible for delivering the message or attachment to the intended recipient you are hereby notified that any dissemination, distribution or copying of this message or any attachment is strictly prohibited. If you have received this communication in error, please notify us immediately by replying to the sender. The information transmitted in this message and any attachments may be privileged, is intended only for the personal and confidential use of the intended recipients, and is covered by the Electronic Communications Privacy Act, 18 U.S.C. §2510-2521.<br class=""></font><span style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; float: none; display: inline !important;" class=""></span><span style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; float: none; display: inline !important;" class="">_______________________________________________</span><br style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none;" class=""><span style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; float: none; display: inline !important;" class="">NCAP-Discuss mailing list</span><br style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none;" class=""><span style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; float: none; display: inline !important;" class=""><a href="mailto:NCAP-Discuss@icann.org" class="">NCAP-Discuss@icann.org</a></span><br style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none;" class=""><span style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; float: none; display: inline !important;" class=""><a href="https://mm.icann.org/mailman/listinfo/ncap-discuss" class="">https://mm.icann.org/mailman/listinfo/ncap-discuss</a></span><br style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none;" class=""><br style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none;" class=""><span style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; float: none; display: inline !important;" class="">_______________________________________________</span><br style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none;" class=""><span style="caret-color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; float: none; display: inline !important;" class="">By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (<a href="https://www.icann.org/privacy/policy" class="">https://www.icann.org/privacy/policy</a>) and the website Terms of Service (<a href="https://www.icann.org/privacy/tos" class="">https://www.icann.org/privacy/tos</a>). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.</span></div></blockquote></div><br class=""></div></body></html>